Jamil Khurram — SEC Form 4 filings

SEC reporting owner CIK 2032345. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2024-08-05 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GALECTIN THERAPEUTICS INC (GALT)Chief Medical Officer1218 legs · 298,750 sh · $1,447,77534

Form 4 filings — Jamil Khurram

FiledFormIssuerReported transactionsSource
2026-07-164GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 16,250 @ $3.04 · Sale (S): 16,250 @ $5.13 · Option exercise (M): 16,250 (derivative) @ $0EDGAR
2026-06-304GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 2,037 @ $2.20 · Sale (S): 2,037 @ $5 · Option exercise (M): 2,533 @ $2.50 · Sale (S): 2,533 @ $5 · Option exercise (M): 47,467 @ $2.50 · Sale (S): 47,467 @ $5.04 · +3 moreEDGAR
2026-06-254GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 7,557 @ $1.23 · Sale (S): 7,557 @ $3.14 · Option exercise (M): 7,557 (derivative) @ $0EDGAR
2026-05-284GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 568 @ $1.23 · Sale (S): 568 @ $3.10 · Option exercise (M): 568 (derivative) @ $0EDGAR
2026-01-214GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-01-064GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 60,000 @ $0 · Sale (S): 13,055 @ $4.20 · Sale (S): 25,499 @ $3.90 · Sale (S): 21,446 @ $3.65 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2026-01-054GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 8,125 @ $1.23 · Sale (S): 8,125 @ $4.07 · Option exercise (M): 8,125 (derivative) @ $0EDGAR
2025-12-194GALECTIN THERAPEUTICS INC (GALT)Sale (S): 4,479 @ $7.04 · Option exercise (M): 6,463 @ $2.20 · Sale (S): 6,463 @ $7.04 · Option exercise (M): 8,500 @ $2.50 · Sale (S): 8,500 @ $7.04 · Option exercise (M): 6,463 (derivative) @ $0 · +1 moreEDGAR
2025-11-144GALECTIN THERAPEUTICS INC (GALT)Sale (S): 21,867 @ $5.47 · Option exercise (M): 41,500 @ $2.20 · Sale (S): 41,500 @ $5.47 · Option exercise (M): 41,500 @ $2.50 · Sale (S): 41,500 @ $5.47 · Option exercise (M): 16,250 @ $1.23 · +4 moreEDGAR
2025-01-274GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-12-264GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 40,000 @ $0 · Sale (S): 13,654 @ $0.88 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-08-054GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2032345 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →